Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Financing Activities (2016 - 2025)

CorMedix (CRMD) has disclosed Cash from Financing Activities for 13 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 112.52% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238.5 million through Dec 2025, up 806.01% year-over-year, with the annual reading at $238.5 million for FY2025, 806.01% up from the prior year.
  • Cash from Financing Activities hit -$1.4 million in Q4 2025 for CorMedix, down from $150.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $150.5 million in Q3 2025 to a low of -$1.4 million in Q4 2025.
  • Historically, Cash from Financing Activities has averaged $22.1 million across 5 years, with a median of $6.1 million in 2025.
  • Biggest YoY gain for Cash from Financing Activities was 7778.42% in 2025; the steepest drop was 112.52% in 2025.
  • Year by year, Cash from Financing Activities stood at $176992.0 in 2021, then skyrocketed by 3315.74% to $6.0 million in 2022, then grew by 19.1% to $7.2 million in 2023, then surged by 56.73% to $11.3 million in 2024, then tumbled by 112.52% to -$1.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CRMD at -$1.4 million in Q4 2025, $150.5 million in Q3 2025, and $83.2 million in Q2 2025.